Gayatri Bioorganics Share Price Gains 3.49% After Q1 FY27 Results on 4 August 2026

The Gayatri Bioorganics share price gained 3.49% to Rs 7.12 on 4 August 2026 as the company reported Q1 FY27 results, with revenue was broadly flat year on year at Rs 0 Cr and net profit was flat year on year at Rs 0 Cr. Investors tracking the Gayatri Bioorganics share price reacted to a quarterly report that delivered Rs 0 Cr in consolidated revenue and Rs 0 Cr in net profit for the quarter ended 30 June 2026. The Gayatri Bioorganics share price movement on results day is one of the first data points investors use to gauge market sentiment around the company Q1 FY27 performance, even before studying the underlying financials in detail.

Click Here – Get Free Investment Predictions

Gayatri Bioorganics Q1 FY27 Results at a Glance

The table below summarises the key Q1 FY27 metrics that drove the Gayatri Bioorganics share price reaction on 4 August 2026.

Metric	Q1 FY27 (Jun 2026)	Q1 FY26 (Jun 2025)	YoY Change
Gayatri Bioorganics	Q1 FY27 Results on 4 August 2026
Revenue	Rs 0 Cr	Rs 0 Cr	0.00%
Net Profit (PAT)	Rs 0 Cr	Rs 0 Cr	0.00%
Gross Margin	0.5%
Share Price on 4 Aug 2026	Rs 7.12	N/A	+3.49% on 4 Aug

Gayatri Bioorganics Share Price Reaction to Q1 FY27 Results

The Gayatri Bioorganics share price move of +3.49% to Rs 7.12 on 4 August 2026 is the market first verdict on the Q1 FY27 numbers. Share price moves on results days are driven by whether the actual figures beat or missed analyst expectations ahead of the announcement. The Gayatri Bioorganics share price reaction should be read alongside the underlying financials: revenue of Rs 0 Cr (0.00% YoY) and PAT of Rs 0 Cr (0.00% YoY) are the two metrics that will drive analyst estimate revisions for FY27.

Post-result volatility in the Gayatri Bioorganics share price is normal and typically settles over the following sessions as institutional investors complete their position adjustments. Investors who hold the Gayatri Bioorganics share price through earnings should focus on the fundamental trend rather than the single-day price move, which can be amplified by event-driven traders unwinding pre-result positions.

Screen Gayatri Bioorganics and Peers on the Univest Screener

Key Business Factors Behind the Gayatri Bioorganics Share Price Move

Revenue Performance in Q1 FY27

Gayatri Bioorganics reported revenue of Rs 0 Cr for Q1 FY27, was flat 0.00% year on year from Rs 0 Cr in Q1 FY26. Revenue trajectory is the starting point for understanding why the Gayatri Bioorganics share price moved the way it did on 4 August 2026. Investors tracking the Gayatri Bioorganics share price should monitor whether this revenue growth rate sustains into Q2 FY27 (September quarter) or represents a seasonal or one-off dynamic that may not repeat.

Profitability and Margin Trends

The PAT of Gayatri Bioorganics for Q1 FY27 was stable to Rs 0 Cr from Rs 0 Cr in Q1 FY26, a change of 0.00% year on year. The gross margin stood at 0.5% for the quarter. Profitability trends are a key driver of the Gayatri Bioorganics share price over the medium term, as consistent earnings improvement is what typically drives institutional accumulation of a stock. Investors holding the Gayatri Bioorganics share price should track whether this profit trajectory is sustainable into Q2 and Q3 FY27.

What Investors Should Watch in the Gayatri Bioorganics Share Price

Beyond the Q1 FY27 results, several factors will influence the Gayatri Bioorganics share price trajectory in the coming months. Management commentary on the Q2 FY27 outlook, particularly on demand trends, input cost movements, and any guidance upgrades or downgrades, will be closely watched. The Gayatri Bioorganics share price is also subject to broader market conditions including RBI monetary policy, FII activity, and sector-level sentiment.

For investors evaluating the Gayatri Bioorganics share price at current levels of Rs 7.12, the Q1 FY27 results provide a baseline. The sustainability of the revenue run rate at Rs 0 Cr per quarter and the profit level at Rs 0 Cr will determine whether the Gayatri Bioorganics share price re-rates higher or faces consolidation in subsequent sessions.

Download the Univest iOS App or Univest Android App to track the Gayatri Bioorganics share price and access Q1 FY27 results analysis.

Conclusion

The Gayatri Bioorganics share price gained 3.49% to Rs 7.12 on 4 August 2026 after the company reported Q1 FY27 results showing revenue of Rs 0 Cr (0.00% YoY) and PAT of Rs 0 Cr (0.00% YoY). The Gayatri Bioorganics share price reaction reflects the market initial assessment of the Q1 FY27 print. Investors should track Q2 FY27 results (due around October 2026) and management guidance for a more complete picture of the FY27 earnings trajectory before making significant decisions based on the The company at current levels.

Frequently Asked Questions

What happened to the The stock after Q1 FY27 results?

Ans. The The shares gained 3.49% to Rs 7.12 on 4 August 2026, reacting to Q1 FY27 results that showed revenue of Rs 0 Cr and PAT of Rs 0 Cr.

What were the Gayatri Bioorganics Q1 FY27 results?

Ans. Gayatri Bioorganics reported revenue of Rs 0 Cr (0.00% YoY) and PAT of Rs 0 Cr (0.00% YoY) for Q1 FY27 (April to June 2026 quarter) announced on 4 August 2026.

What is the The scrip today?

Ans. The The counter was Rs 7.12 on 4 August 2026, the day Q1 FY27 results were announced. For the latest The company, check NSE (nseindia.com) or the Univest app.

Is Gayatri Bioorganics a good buy after Q1 FY27 results?

Ans. Any decision to buy The stock should be based on your own research and risk profile. Q1 FY27 results show PAT of Rs 0 Cr and revenue of Rs 0 Cr. Consult a SEBI-registered advisor before investing.

What is the PAT of Gayatri Bioorganics for Q1 FY27?

Ans. The PAT (net profit) of Gayatri Bioorganics for Q1 FY27 was Rs 0 Cr, a change of 0.00% year on year from Rs 0 Cr in Q1 FY26.

Where can I track the The shares?

Ans. The The scrip can be tracked on NSE (nseindia.com), BSE (bseindia.com), and the Univest app and screener for live prices, Q1 FY27 results analysis, and investor research.